Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2019-08-29 to 2023-08-31
Current total value of award: $295920
Description: CLONOSEQ TESTING SERVICES